Skip to main navigation
logo
  • Overview
  • News & Events
    • News Releases
    • Events & Presentations
  • Governance
    • Governance Overview
    • Board of Directors
    • Leadership
    • Committee Composition
  • Financials
    • SEC Filings
    • IRS Form 8937
  • Stock
    • Stock Quote & Chart
    • Historic Price Lookup
    • Investment Calculator
    • Analyst Coverage
  • Resources
    • Investor FAQs
    • Settlement Information
    • Email Alerts
    • RSS Feeds
    • IR Contact

News Release Details

« Back

ARM Cell and Gene Therapies State of the Industry Briefing

Jan 7, 2019
|
PDF Version
Carisma Therapeutics CEO, Steven Kelly, to speak at the Cell Therapy Commercialization in Oncology panel during the ARM Cell and Gene Therapies State of the Industry Briefing in San Francisco, CA.

Site - Investor Tools

  • Print Page
  • Email Alerts
  • RSS Feeds
  • IR Contact

© 2026 Carisma Therapeutics Inc.  All rights reserved.